Infant Bacterial Therapeutics AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2023-12-28 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 245 | 90,8 | SEK | 22 246 | 2023-12-27 |
| 2024-02-08 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 161 | 94 | SEK | 15 134 | 2024-02-07 |
| 2024-02-08 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 839 | 94,2 | SEK | 79 033,8 | 2024-02-07 |
| 2024-03-04 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 38 | 79,8 | SEK | 3 032,4 | 2024-03-03 |
| 2024-03-04 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 422 | 80 | SEK | 33 760 | 2024-03-03 |
| 2024-05-10 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 1 250 | 90 | SEK | 112 500 | 2024-05-09 |
| 2024-05-10 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 178 | 89 | SEK | 15 842 | 2024-05-09 |
| 2024-05-10 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 894 | 92 | SEK | 82 248 | 2024-05-09 |
| 2024-05-10 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 128 | 90 | SEK | 11 520 | 2024-05-09 |
| 2024-05-13 | Infant Bacterial Therapeutics AB | Margareta Hagman | Member of the Board of Directors | Acquisition | 1 000 | 93,41 | SEK | 93 409,8 | 2024-05-12 |
| 2024-05-14 | Infant Bacterial Therapeutics AB | Eva Idén | Member of the Board of Directors | Acquisition | 200 | 89,8 | SEK | 17 960 | 2024-05-09 |
| 2024-05-17 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 89 | 97,6 | SEK | 8 686,4 | 2024-05-16 |
| 2024-05-17 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 56 | 97,2 | SEK | 5 443,2 | 2024-05-16 |
| 2024-05-17 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 37 | 96,2 | SEK | 3 559,4 | 2024-05-16 |
| 2024-05-17 | Infant Bacterial Therapeutics AB | Anthon Jahreskog | Member of the Board of Directors | Acquisition | 88 | 96,8 | SEK | 8 518,4 | 2024-05-16 |
| 2024-05-28 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 4 | 96 | SEK | 384 | 2024-05-27 |
| 2024-05-28 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 152 | 95,8 | SEK | 14 561,6 | 2024-05-27 |
| 2024-05-31 | Infant Bacterial Therapeutics AB | Staffan Strömberg | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 50 000 | 12,2 | SEK | 610 000 | 2024-05-27 |
| 2024-05-31 | Infant Bacterial Therapeutics AB | Anders Kronström | Other senior executive | Acquisition | 25 000 | 12,2 | SEK | 305 000 | 2024-05-27 |
| 2024-05-31 | Infant Bacterial Therapeutics AB | Maria Ekdahl | Chief Financial Officer (CFO) | Acquisition | 25 000 | 12,2 | SEK | 305 000 | 2024-05-27 |